Integrating cervical cancer screening and care with other health service delvery systems through innovative solutions
Wednesday 4 mai 9.00 – 16.00
Room Lausanne
In English
Presentation
Since some years the fight against cervical cancer (CC) has gained the interest of the international community: updated WHO recommendations are available, new technologies allowed diagnostic simplification and same day treatment became possible. However, the objective of elimination of CC as a public health problem is far from being reached. A number of organizations and institutions have engaged in developing and testing strategies and techniques to improve the different steps in the fight against CC. GHF has organized and sponsored a serial of meetings about innovative solutions and its partners worked to pilot their implementation.
This workshop aims at presenting and exchanging the latest experiences and sharing the new technologies and innovative practices and solutions with the objective of:
- Discussing key recommendations for implementation of integrated cervical cancer screening and care strategies
- Fostering donors’ investments in comprehensive gynecological care
- Discuss other possible actions to accelerate efforts towards the elimination of cervical cancer
| 09.00 – 09.15 | Welcome and introduction | |
| 9.15 – 12.00 | Integrating cancer screening and care with other health service delivery systems: Issues of concern and opportunities | Moderator: Nicholas Furtado (Global Fund) Vanessa Christinet (ASCRES/CIRES) |
| 9.15 – 10.45 | Importance of integrating cervical cancer and HIV services and programs: enabling policies and best practices | Ani Shakarishvili (UNAIDS) |
| Integration of Female Genital Schistosomiasis (FGS) and cervical cancer programs: diagnostics, care and delivery | Amadou Garba (WHO NTD) | |
| FGS training to build capacity for cervical cancer health staff: an opportunity that should not be missed” | Vanessa Christinet (ASCRES/CIRES) | |
| MSF cervical cancer programs: where are we now? | Nelly Staderini (MSF) | |
| Civil society mobilisation and advocacy to drive equitable access to innovation for cervical cancer cancer elimination | Melanie Samson (UICC) | |
| Cervical cancer screening among women with Type 3 Transformation Zone of the cervix | Simon Manga (Cameroon Baptist Convention Health Services. CBCHS) | |
| 10.45 – 11.15 | Coffee Break | |
| 11.15 – 12.00 | Discussion and recommendations | |
| 12.00 – 13.30 | Lunch | |
| 13.30 – 15.30 | Moving forward for screening and diagnosis | Moderators: Sergio Carmona (FIND), Laura Ciaffi (ASCRES/CIRES) |
| 13.30 -14.30 | Oncomarkers : Integrating Cellular Biomarkers into HPV Testing: One Stop Dysplasia Diagnosis Test by QuantiGene-Molecular-Profiling-Histology Assay. | Andreas M. Kaufmann (Charité-Universitätsmedizin Berlin, Dept. for Gynecology, Research, Germany) |
| Oncomarkers : RDT for HPV induced cancer | Anna Huber (Abviris) | |
| Artificial Intelligence in cervical cancer screening – hype or hope? | Partha Basu (IARC) | |
| Artificial intelligence : Smart Scope – A Success Story of AI-enabled Point-of-care Screening at Scale | Veena Moktali & Koustubh Naik (Periwinkle) | |
| Artificial intelligence : A personalized cervical cancer screening using AI | Holly Clarke (HUG) | |
| Artificial intelligence : Feasibility of using machine learning-based AI systems in cervical cancer screening | Magali Cattin (EPFL) | |
| 14.30 – 15.00 | Discussion et recommendations | |
| 15.00 – 15.30 | Coffee Break | |
| 15.30 – 16.00 | Wrap up and plan of action | |